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Introduction
Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is a transferase enzyme 
that catalyzes conversion of hypoxanthine into inosine monophosphate (IMP); and 
guanine to guanosine monophosphate (GMP) (1). This enzyme provide cells with 
alternatives to the energy-expensive de novo synthesis of nucleotides and plays 
a critical role in the maintenance of intracellular purine nucleotide pools in cells 
that have decreased ability to synthesize new nucleotides (e.g. erythrocytes) (2). A 
deficiency of HGPRT in males results in a spectrum of disease, the severity of which 
is dependent upon the extent of the deficiency. A complete deficiency of the enzyme 
is associated with the Lesch-Nyhan syndrome (LNS) (incidences of 1 in 100,000), 
while partial deficiency is associated with gout (incidences 1 in 200 among males 
with gout) (3). LNS was first described by M. Lesch and W. Nyhan in 1964 as a 
complete deficiency of activity reported in two brothers (4) and clinically associated 
with neurologic dysfunction, cognitive and behavioral disturbances including self-
mutilation, and uric acid overproduction (hyperuricemia). Most patients with LNS 
usually expire in childhood from renal failure and infection; and survival into second 
decade of life is known but rare (5). Sudden and unexpected deaths have respiratory 
rather than cardiogenic origins (6). Neurological symptoms affect the motor sphere 
and the cognitive and behavioral aspects (7). HGPRT is encoded in humans via 
the HPRT1 gene (size 42.5 kbp) (8) on the X chromosome in the region q26-q27 
with only one transcript (9) and consists of 9 exons with a coding sequence of 654 
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Deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) 
is a rare inborn error of purine metabolism and is characterized by uric acid 
overproduction along with a variety of neurological manifestations that depend 
on a degree of the enzymatic deficiency. Inheritance of HPRT deficiency is 
X-linked recessive; thus, males are generally more affected and heterozygous 
females are carriers (usually asymptomatic). Human HPRT is encoded by a 
single structural gene on the long arm of the X chromosome at Xq26. More 
than 300 mutations in the HPRT1 gene have been detected. Diagnosis can be 
based on clinical and biochemical findings as well as enzymatic and molecular 
testing. Molecular diagnosis is the best way as it allows for faster and more 
accurate carrier and prenatal diagnosis. In this report, a new small duplication in 
the HPRT1 gene was found by sequencing, which has yet to be reported.
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bp (10). There are high degrees of heterogeneity in type 
and location within the gene (7). At least 400 different 
mutations in the HPRT coding parts of exons 1 to 9 are 
specified and mutations of substitution, frame shift, 
micro deletion, macro deletion, insertion, and splicing 
errors have been described as the cause of HGPRT 
deficiency (11, 12). However, about 30% of patients’ 
mothers are not somatic carriers; these patients probably 
carry de novo mutations due to a germinal cell mutation 
that requires genomic DNA sequencing (7). Here, we 
report a new small duplication that was detected by 
sequencing the entire HPRT1 gene in an Iranian family.
 
Case report
A woman (Consultand) had a mentally retarded brother 
who expired 15 years ago, was referred to the Medical 
Genetics Center. The patient’s parents were unrelated 
and there was a similar disease in her uncle’s son. The 
patient also had three uncles who expired under one year 
of age. 
The patient’s uncle was married to a cousin and her 
uncle’s wife has a nephew with a similar disease who 
expired at 12 years of age (Figure 1).
 
Fig 1. Consultand family pedigree.
According to the observations of the parents, the 
proband was quiet, hypotonic with neuro-developmental 
delays from birth. Metabolic and ultrasound screening 
was normal. The clinical findings were not shown until 
three years of age. From this time, the child started to 
say words and exhibited self-mutilation behavior that 
started with biting his clothes and chewing his fingers. 
He (brother of Consultand) has also had other clinical 
aspects of gastrointestinal defects such as constipation, 
kidney stones (staghorn calculus), hematuria, and finally 
expired due to a heart problem.
Based on these findings LNS was considered. 
Identification of mutations has been performed at the 
RNA and DNA levels. Sequencing genomic DNA of 
the HPRT gene offers the possibility of direct diagnostic 
analysis independent on the expression of the mature 
HPRT mRNA (13). Accordingly, DNA was extracted 
and direct DNA sequencing was performed with dye 
terminators in her mother (molecular genetic analysis was 
performed by the Center for Nephrology and Metabolic 
Disorder Deutschland/Germany). The fragments were 
separated by capillary electrophoresis (ABI Prism 3130). 
All coding regions (exons) and the bordering invariant 
splice junction were sequenced for a total of 7,931 bp. 
The interpretation of the sequence data follows GenBank 
entry 00194. The c.105_106 duplication (GT) in exon 2 
(codon 36) was found. The mutation is not yet in the 
database version available to us [especially PubMed 
indexed for MEDLINE (PMID), Single Nucleotide 
Polymorphism indexed for MEDLINE (SNPID)], but its 
pathogenic relevance is obvious as it causes a protein 
truncation in exon 3 (codon 16, ATC).
Replication slippage is a commonly observed DNA 
replication error that is often facilitated by a repetitive 
sequence (14) and leads to short sequence duplications 
or deletions and if the mutation occurs in a coding region, 
it could produce abnormal proteins and leads to diseases 
(15). In fact, the mother (III-3) was heterozygous for this 
mutation. This mutation was studied in the consultand 
(IV-3) and she was like her mother. Therefore, the risk of 
the recurrence of LNS for her sons was raised to 50%. If 
the mutation is identified in NLS suspected individuals 
(IV-6), it may be concluded that the origin of the mutation 
in I-1 or I-2. Therefore, clinical examinations and further 
tests are required to prove NLS in this family.
Discussion 
Since the inheritance of HPRT deficiency is X-linked 
recessive, males are generally
More affected and heterozygous female are the carriers. 
For families with an affected person, carrier diagnosis is 
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an important issue. Female carriers cannot be detected 
without the help of a laboratory since they are usually 
asymptomatic (16). However, their mosaicism in terms 
of HPRT activity, such diagnosis is not infallible (17) and 
molecular methods allow for faster and more accurate 
carrier diagnosis (18). Therefore, with the approval of 
the carriers, prenatal diagnosis can be performed by 
amniocentesis at about 15–18 weeks of gestation, or 
chorionic villus sampling (CVS) at about 10–12 weeks 
gestation for the known disease-causing mutation (19, 
20).
Since more than 300 mutations in this gene have been 
identified, there is also the possibility of identifying a 
new mutation. The direct DNA sequencing is one of 
the best ways to identify new mutations as many new 
mutations have been previously identified in this way as 
exampled in Gibbs et al (21) and Mak et al (22).
In this family, detection of duplication mutations in 
exon-2 HPRT1 gene in the patient’s sister and this type 
of mutation is a frame-shift mutation, it is thought that 
the patient had a severe loss of enzyme activity. This loss 
could be the reason for the severity of the illness and the 
inability to survive into the early second decade of life. 
Thus, prenatal diagnosis must be performed to identify 
the affected or carriers fetuses in males and females, 
respectively.
Despite the lack of complete and reliable treatment 
due to a lack of knowledge for all aspects of clinical 
and metabolic effects, accurate and timely diagnosis 
of deadly diseases such as LNS due to clinical follow-
up can be effective in reducing the severity of diseases 
and increase survival to the second or third decades of 
life. All these processes require accurate and reliable 
methods.
Knowledge of the molecular basis of the disease in this 
family could help people at risk and improve genetic 
counseling.
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